Science Explorer Interactive view Map
Company · Seoul · South Korea

Bristol-Myers Squibb (South Korea)

bms.com/krROR OpenAlex
Research works
37
▼ 35% vs 2013–17
Citations
413
11.1 per fractional work
Top-10% rate
16.0%
record average 16.5%
Open access
45%
world 28%

Not ranked overall: Bristol-Myers Squibb (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.21× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.67× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 1.16× its world share, 0 worksImmunology and Micro…Neuroscience: 1.35× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.91× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.17× its world share, 0 worksChemistryComputer Science: 0.59× its world share, 0 worksComputer ScienceEngineering: 0.74× its world share, 1 worksEngineeringEnvironmental Science: 0.98× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.28× its world share, 0 worksMaterials ScienceHealth Professions: 1.74× its world share, 0 worksHealth ProfessionsMedicine: 2.32× its world share, 5 worksMedicineVeterinary: 5.38× its world share, 0 worksVeterinaryArts and Humanities: 0.34× its world share, 0 worksArts and HumanitiesPsychology: 0.19× its world share, 0 worksPsychologySocial Sciences: 0.19× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.9×. Every wedge is a field page.

Which keywords describe research at Bristol-Myers Squibb (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Immunotherapy, Prognostic Factors, Targeted Therapy, Tumor Microenvironment, Epidemiology, Lymphoma and Chemotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 12 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 12 words, with their numbers
  1. Cancer3▲ 6.0×16 topics
  2. Epidemiology2▲ 1.61×21 topics
  3. Immunotherapy2▲ 7.7×14 topics
  4. Prognostic Factors2▲ 8.7×8 topics
  5. Targeted Therapy1▲ 17×4 topics
  6. Chemotherapy1▲ 4.8×13 topics
  7. Oxidative Stress1▲ 1.95×15 topics
  8. Tumor Microenvironment1▲ 9.5×6 topics
  9. Quality of Life1▲ 2.1×7 topics
  10. Clinical Trials1▲ 4.4×5 topics
  11. Lymphoma1▲ 19×3 topics
  12. Resistance Mechanisms1▲ 36×2 topics

Which research topics does Bristol-Myers Squibb (South Korea) publish most on?

By volume in 2022–2025: Lung Cancer Diagnosis and Treatment, Radiomics and Machine Learning in Medical Imaging, Lymphoma Diagnosis and Treatment and Cancer, Hypoxia, and Metabolism.

Lung Cancer Diagnosis an…0Lung Cancer Diagnosis and Treatment: 0 fractional worksRadiomics and Machine Le…0Radiomics and Machine Learning in Medical Imaging: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksBlockchain Technology Applications and Security: 0 fractional worksNoise Effects and Management: 0 fractional worksElectrochemical sensors …0Electrochemical sensors and biosensors: 0 fractional worksAntimicrobial agents and applications: 0 fractional worksLung Cancer Treatments and Mutations: 0 fractional works
Pulmonary and Respiratory MedicineRadiology, Nuclear Medicine and ImagingPathology and Forensic MedicineCancer Research5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  2. 2 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  4. 4 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  5. 5 CAR-T cell therapy research Oncology 0 works
  6. 6 Blockchain Technology Applications and Security Information Systems 0 works
  7. 7 Noise Effects and Management Speech and Hearing 0 works
  8. 8 Electrochemical sensors and biosensors Electrical and Electronic Engineering 0 works
  9. 9 Antimicrobial agents and applications Organic Chemistry 0 works
  10. 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.4%not open54.6%

World: 28% of research is openly available.

with international co-authors33.7%domestic only66.3%

World: 19% is written across borders.

How has Bristol-Myers Squibb (South Korea)'s research output changed?

Output in 2018–2022 was 35% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seoul

All research institutions in Seoul

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.